BB's Stock Haven

[cjstocksup]

BSSP .0006
BSSP Valuation to Consider
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122284773

I must say first that I believe that the initial thoughts were correct with assessing the Stage 3 clinical trials in Europe to be for the therapy to treat HIV at a hospital in Bulgaria. It is known that it was a Bulgarian Hospital that gave Dr. Zhabilov $2 million USD so the Irreversible Pepsin Fraction (IPF) therapy for HIV could get approved in Europe (EU). Although BSSP/Canteck Pharma, Inc. did not mention such within their recent PR and only mentioned that they have current and planned operations in Mexico through the exclusive Sub Licensing Agreement for IPF specific to the Cancer, there is some serious research that confirms your initial research on the matter within the slideshow below:
http://www.cantechpharma.com/wp-content/uploads/2016/02/Cantech-IPF.pdf